For instance, in 2017, a prospective study of multigene panel testing by Pearlman et al. [30] examined the frequency of BRCA1/2 mutations in 450 CRC patients younger than 50 years (early-onset CRC). The gene discussed is BRCA1; the disease is colorectal carcinoma.